Optibrium Unveils StarDrop 4.3

Delivering Enhanced Features to Guide Decisions for Drug Optimisation CAMBRIDGE, UK -- Optibrium, a provider of software solutions for drug discovery, today launches StarDrop 4.3. The intuitive software offers advantages over traditional predictive modeling platforms as it specifically helps users to identify chemistries with a high chance of success and focus expensive in-house resources. Used [...]

Thermo Fisher Scientific Ships 2000th iCAP 6000 Series ICP Emission Spectrometer

CAMBRIDGE, UK -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced that Bormioli Rocco, a producer of glass and plastic pharmaceutical packaging, glass containers for perfumery and foodstuffs and glass tableware, has purchased and deployed the 2000th Thermo Scientific iCAP 6000 Series inductively coupled plasma (ICP) emission spectrometer. The company relies [...]

QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients

MANCHESTER, England & NEW YORK--Pfizer Inc. (NYSE: PFE) and DxS (a wholly owned subsidiary of QIAGEN N.V.) (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced that they have entered into an agreement to develop a companion diagnostic test kit for PF-04948568 (CDX-110), an immunotherapy vaccine in development for the treatment of glioblastoma multiforme (GBM). Financial [...]

/C O R R E C T I O N — Arrayit Corporation/

In the news release, Arrayit Wins Landmark DNA Testing Patent in Israel, issued 04-Feb-2010 by Arrayit Corporation over PR Newswire, we are advised by the company that Patent Number 153848 in the first sentence of the second paragraph should link to the following website: https://www.ilpatsearch.justice.gov.il/UI/MainPage.aspx. The complete, corrected release follows: Arrayit Wins Landmark DNA Testing [...]

Linden Acquires Hycor Biomedical Business from Agilent Technologies

CHICAGO & SANTA CLARA, Calif.--Linden LLC, a Chicago-based healthcare private equity firm, today announced it has acquired Hycor Biomedical Inc. from Agilent Technologies (NYSE:A). Hycor develops, manufactures and markets in vitro diagnostic products for the global allergy, autoimmune and urinalysis markets. Agilent acquired Hycor through its acquisition of Stratagene in 2007. The terms of the [...]

ABB Introduces its Versatile MB3600-PH FT-NIR Spectrometer

MB3600-PH provides exceptionally accurate measurements for a broad range of pharmaceutical and life science applications; spectrometer is easy to use with minimal maintenance requirements Québec, Canada -- ABB, the leading power and automation technology group, announced today the introduction of its versatile MB3600-PH FT-NIR spectrometer for the pharmaceutical and life sciences industries. This exceptionally accurate [...]

William D. Young Joins NanoString Technologies as Executive Chairman of the Board

SEATTLE--NanoString Technologies, Inc., a privately held life sciences company marketing a complete solution for detecting and counting large sets of target molecules in biological samples, today announced that it has appointed William D. Young as Executive Chairman of its Board of Directors. “Bill’s unique experience in clinical diagnostics and biotechnology is an ideal combination for [...]

Laboratory Products Leader Sterlitech Expands RO Membranes Line

Sterlitech Corporation New Line of Toray Flat Sheet Reverse Osmosis Membranes - Now Boasts an Exhaustive Variety of Superior R&D Membrane Products Kent, WA (PRWEB) -- Sterlitech Corporation, one of the largest producers of bench scale equipment for flat sheet membranes used in research and development labs throughout the globe, is pleased to announce the [...]

Picarro Chosen by California for First State-Level Greenhouse Gas Emissions Measurement Network

SUNNYVALE, Calif.--The California Air Resources Board (CARB) has purchased seven Picarro gas analyzers as part of the Board's efforts to quantify emissions of the greenhouse gases (GHGs) in California. The Picarro analyzers will be used by CARB to measure methane emissions as part of the fulfillment of the Board’s mandate under California State Law AB [...]

Dr. Klaus Lindpaintner Begins Serving as Vice President of R&D and CSO for Strategic Diagnostics

NEWARK, Del.--SDI (Strategic Diagnostics Inc., Nasdaq: SDIX), a provider of biotechnology-based products and services, today announced that Dr. Klaus Lindpaintner began serving as Vice President of Research & Development and Chief Scientific Officer (CSO) on February 1, 2010 as previously disclosed in its January 11, 2010 news release. Prior to joining SDI, Dr. Lindpaintner was [...]

Access IBO on Knowledge Center